Author:
Manganoni Ausilia Maria,Farisoglio Camillo,Ferrari Vittorio,Zaniboni Alberto,Beretta Giordano,Meriggi Fausto,Calzavara-Pinton Piergiacomo
Publisher
Springer Science and Business Media LLC
Reference4 articles.
1. Manganoni AM, Farisoglio C, Ferrari V, et al. Multidisciplinary team-working indicators of good practice in the clinical management of EGFR-inhibitor dermatologic toxicities. Ann Surg Oncol. 2008 Nov 7. [Epub ahead of print].
2. Segaert S, Tabernero J, Chosidow O, et al. The menagement of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies. J Dtsch Dermatol Ges. 2005;3:599–606.
3. Saltz LB, Meropol NJ, Loehrer PJ, Needle MN, Kopit J, Mayer RJ. Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. J Clin Oncol. 2004;22:1201–8.
4. Eaby B, Culkin A, Lacouture ME. An interdisciplinary consensus on managing skin reactions associated with human epidermal growth factor receptor inhibitors. Clin J Oncol Nurs. 2008;12(2):283–90.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献